Clinical Trials on Primary Care Physician in Germany

Total 11246 results

Heidelberg University
Merck Sharp & Dohme LLC

Recruiting

Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH (RIVERII)

Chronic Thromboembolic Pulmonary Hypertension | Primary Pulmonary Arterial Hypertension

Germany
OxThera
FP7-SME-2013 Research for the benefit of SMEs program

Completed

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

France, Germany, United Kingdom
University of Erlangen-Nürnberg Medical School

Unknown

Protein Supplementation and HIIT: Impact on Cardiorespiratory Fitness

Health Promotion | Primary Prevention

Germany
University Hospital Heidelberg
Deutsche Krebshilfe e.V., Bonn (Germany)

Unknown

Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer (OVAR-IMRT-02)

Ovarian Cancer | Primary Peritoneal Carcinoma | Tubal Carcinoma

Germany
Universitätsklinikum Hamburg-Eppendorf
Johannes Gutenberg University Mainz; Institute for Clinical Molecular Biology...

Completed

Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC) (PSt-GFD)

Reduction of Intestinal Inflammatory Activity

Germany
Martin-Luther-Universität Halle-Wittenberg

Completed

Autonomic Dysfunction and Inflammation in Chronic Hemodialysis Patients

Chronic Renal Failure | Autonomic Dysfunction

Germany
Universität des Saarlandes

Completed

Predictors of Individual Training Effectiveness in Preventive Exercise

Primary Prevention

Germany
Eli Lilly and Company

Terminated

Instillation of Gemcitabine in Patients With Superficial Bladder Cancer

Bladder Neoplasms

Germany
Bionorica SE

Completed

Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs

Urinary Tract Infection

Germany
University Hospital Heidelberg

Unknown

Nivolumab/Ipilimumab in Second Line CUP-syndrome (CheCUP)

Cancer of Unknown Primary Site

Germany
Dicerna Pharmaceuticals, Inc.

Completed

Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria

Primary Hyperoxaluria

United States, France, Germany, Netherlands, United Kingdom
Universität Duisburg-Essen
Merck Sharp & Dohme LLC

Completed

Rizatriptan 10 MG RPD in the Treatment of Acute Migraine (Rinotama)

Migraine

Germany
University of Erlangen-Nürnberg Medical School

Recruiting

Tissue K+ in Primary Hyperaldosteronism

Primary Hyperaldosteronism | Electrolyte Disturbance

Germany
Bayer

Completed

Study to Test the Safety of Increasing Multiple Doses of BAY2328065 Given by Mouth, How the Drug is Tolerated and Acts in the Human Body of Healthy Male Participants. Alteration of the Study Drug Effects by Another Drug and the Availability of the Drug Given in Different Formulations is Also Tested.

Endometriosis

Germany
Tischendorf, Jens, M.D.

Completed

Endoscopic Ultrasound as an Early Diagnostic Tool for Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

Germany
Bruno Allolio

Completed

Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency (PHYSCA)

Primary Adrenal Insufficiency

Germany
Isarna Therapeutics GmbH

Completed

Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy

Primary Open Angle Glaucoma

Germany
Robert Bosch Gesellschaft für Medizinische Forschung...
Norwegian University of Science and Technology

Completed

Evaluation of the Measurement Properties of a 5 Time Repeated Instrumented Timed Up and Go (5iTUG) (5iTUG)

Cognitive Impairment | Physical Disability | Gait Disorder, Sensorimotor | Balance | Activity of Daily Living | Measurement Properties of 5iTUG | Leg Strength

Germany
Hannover Medical School
Hoffmann-La Roche

Completed

Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation

Heart Transplantation

Germany
Hannover Medical School
Hoffmann-La Roche

Completed

Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation

Heart Transplantation

Germany
Octapharma

Completed

Efficacy and Safety of Immunoglobulin Intravenous (Human) 10% (NewGam) in Primary Immune Thrombocytopenia

Primary Thrombocytopenia

Germany
Universität des Saarlandes

Completed

Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia

Benign Prostatic Hyperplasia | Primary Prostate Urothelial Cancer

Germany
University of Cologne

Recruiting

Dietary Interventions During Living Kidney Donations (DILKID)

Living-Kidney Donors

Germany
Technische Universität Dresden
ISMG, Medical Faculty, Otto-von-Guericke University Magdeburg; Scientific Institute...

Recruiting

Evaluation of a Flexible and Integrative Psychiatric Care Model at the Pfalzklinikum (EVA_Pfalz) (EVA_Pfalz)

Mental Health Care

Germany
Hannover Medical School

Recruiting

REBIRTH Active School 2.0 . A School Based Physical Activity Program (RAS2)

Primary School Children

Germany
Egalet Ltd

Completed

Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine

Migraine

Germany
Sanofi

Completed

Levofloxacin, Chronic Bacterial Prostatitis

Prostatitis

Germany
Prof. Dr. Thomas Otto

Completed

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.

Germany
Ludwig-Maximilians - University of Munich
Amgen; ClinAssess GmbH

Not yet recruiting

Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation

Treatment Related Cancer

Germany
OxThera

Terminated

An Extension Study to Evaluate the Long-term Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria (ePHex-OLE)

Hyperoxaluria, Primary

United Kingdom, Spain, Belgium, United States, Germany, Tunisia
Ludwig-Maximilians - University of Munich
Merck KGaA, Darmstadt, Germany; ClinAssess GmbH

Active, not recruiting

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Treatment Related Cancer

Germany
University Hospital Heidelberg

Completed

Carbon Ion Radiotherapy for Primary Glioblastoma (CLEOPATRA)

Primary Glioblastoma

Germany
Heinrich-Heine University, Duesseldorf

Unknown

MicroRNAs in Renal Recovery - Pilot Study

Markers in Plasma and Urine

Germany
Ludwig-Maximilians - University of Munich
University of Hamburg-Eppendorf; Introvision e.V

Unknown

Introvision for Migraine and Headaches (IntroMig)

Migraine | Chronic Migraine

Germany
CTI BioPharma
SGS S.A.

Completed

Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects

Myelofibrosis

Moldova, Republic of, Germany
Alcon Research

Completed

Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Primary Open-angle Glaucoma | Pigment Dispersion Glaucoma

Germany
MerLion Pharmaceuticals GmbH

Completed

Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis

Urinary Tract Infections | Acute Pyelonephritis

Germany
University Hospital Freiburg
Ludwig-Maximilians - University of Munich; University Hospital Heidelberg; University... and other collaborators

Unknown

Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma (PRIMAIN)

Primary Non Hodgkin Lymphoma of the Central Nervous System

Germany
Aesculap AG

Completed

Multi-center Study to Evaluate the Safety and Efficacy of Aesculap MonoMax® for Abdominal Wall Closure (ISSAAC)

Primary Median Laparotomy

Germany
Heidelberg University
Hannover Medical School; University of Leipzig; University Hospital Heidelberg; University of Giessen and other collaborators

Completed

BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension (AMIA)

Pulmonary Arterial Hypertension

Germany
Dr. Falk Pharma GmbH

Completed

Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis (NUC-3)

Primary Sclerosing Cholangitis

Austria, Germany, Norway
Alnylam Pharmaceuticals

Active, not recruiting

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 (ILLUMINATE-B)

Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria

United States, France, United Kingdom, Israel, Germany
Dr. Falk Pharma GmbH

Recruiting

norUrsodeoxycholic Acid vs Placebo in PSC

Primary Sclerosing Cholangitis

Austria, Germany
Bayer

Completed

Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants

Overactive Bladder | Cough | Endometriosis

Germany
Technical University of Munich

Completed

Goal Directed Hemodynamic Management and Renal Outcome After Major Non-cardiac Surgery (IROM)

Major Non-cardiac Surgery

Germany
Oryx GmbH & Co. KG

Completed

Cisplatin-based Chemotherapy Combined With P16_37-63 Peptide Vaccination in Patients With HPV-positive Cancers (VICORYX-2)

HPV-induced Cancers

Germany
Klinikum Stuttgart
University Hospital Freiburg

Terminated

Venetoclax and Obinutuzumab for Relapsed/Refractory Primary CNS Lymphoma (VENOBI-CNS)

Primary CNS Lymphoma

Germany
Dr. Falk Pharma GmbH

Completed

Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Germany
Novartis Pharmaceuticals

Terminated

A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)

Primary Myelofibrosis

Spain, Germany, Italy
University College Dublin
University of Padova; Institut National de Recherche pour l'Agriculture, l'Alimentation... and other collaborators

Recruiting

APPETITE: Plant Protein and Exercise Solutions for the Prevention of Undernutrition in Older Adults.

Aging | Physical Inactivity | Undernutrition | Appetite Loss | Ageing Well | Anorexia of Aging

Germany, Ireland, Italy, France

Clinical Trials on Primary Care Physician in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations